Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Prolensa Generic Name & Formulations
Legal Class
Rx
General Description
Bromfenac 0.07%; oph soln; contains benzalkonium chloride, sulfites.
Pharmacological Class
NSAID.
How Supplied
Soln—1.6mL, 3mL
Manufacturer
Generic Availability
NO
Prolensa Indications
Indications
Post-operative inflammation and reduction of ocular pain following cataract surgery.
Prolensa Dosage and Administration
Adult
≥18yrs: 1 drop into the affected eye once daily beginning 1 day prior to surgery, continued on the day of surgery, and through the first 14 days post-op. May be given with other topical ophthalmics (eg, alpha-agonists, beta-blockers, carbonic anhydrase inhibitors, cycloplegics, mydriatics); administer at least 5 mins apart.
Children
<18yrs: not established.
Prolensa Contraindications
Not Applicable
Prolensa Boxed Warnings
Not Applicable
Prolensa Warnings/Precautions
Warnings/Precautions
Sulfite sensitivity. Asthma. May slow or delay wound healing. Bleeding tendencies. Corneal defects/denervation. Ocular surface diseases. Rheumatoid arthritis. Diabetes. Monitor cornea; discontinue if corneal epithelial breakdown occurs. Risk of corneal adverse events may be increased if used >24hrs before surgery, or beyond 14-days post-op. Contact lenses (remove prior to therapy). Pregnancy (avoid during late pregnancy). Nursing mothers.
Prolensa Pharmacokinetics
See Literature
Prolensa Interactions
Interactions
Concomitant topical corticosteroids may potentiate healing problems. Caution with concomitant drugs that prolong bleeding time.
Prolensa Adverse Reactions
Adverse Reactions
Anterior chamber inflammation, foreign body sensation, eye pain, photophobia, blurred vision; keratitis, corneal reactions (eg, epithelial breakdown, thinning, erosion, ulceration/perforation).
Prolensa Clinical Trials
See Literature
Prolensa Note
Not Applicable
Prolensa Patient Counseling
See Literature
Images
